Neumora Therapeutics, Inc. Common Stock (NASDAQ:NMRA) Q4 2024 Earnings Call Transcript March 3, 2025
Neumora Therapeutics, Inc. Common Stock beats earnings expectations. Reported EPS is $-0.37, expectations were $-0.46.
Operator: Ladies and gentlemen, thank you for standing by. [Operator Instructions] Please be advised that today’s conference is being recorded. I would now like to turn the conference over to Helen Rubinstein, Vice President of Investor Relations and Communications. Please go...
